These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 10725754)

  • 1. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
    Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
    J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
    Kanagawa O; Shimizu J; Vaupel BA
    J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice.
    Verdaguer J; Schmidt D; Amrani A; Anderson B; Averill N; Santamaria P
    J Exp Med; 1997 Nov; 186(10):1663-76. PubMed ID: 9362527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
    Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
    J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype AI4.
    Takaki T; Lieberman SM; Holl TM; Han B; Santamaria P; Serreze DV; DiLorenzo TP
    J Immunol; 2004 Aug; 173(4):2530-41. PubMed ID: 15294969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
    J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
    Mora C; Wong FS; Chang CH; Flavell RA
    J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8+ T cells in nonobese diabetic mice.
    Serreze DV; Choisy-Rossi CM; Grier AE; Holl TM; Chapman HD; Gahagan JR; Osborne MA; Zhang W; King BL; Brown A; Roopenian D; Marron MP
    J Immunol; 2008 Mar; 180(5):3250-9. PubMed ID: 18292549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
    Verdaguer J; Yoon JW; Anderson B; Averill N; Utsugi T; Park BJ; Santamaria P
    J Immunol; 1996 Nov; 157(10):4726-35. PubMed ID: 8906855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
    Serreze DV; Chapman HD; Varnum DS; Gerling I; Leiter EH; Shultz LD
    J Immunol; 1997 Apr; 158(8):3978-86. PubMed ID: 9103469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences.
    Santamaria P; Utsugi T; Park BJ; Averill N; Kawazu S; Yoon JW
    J Immunol; 1995 Mar; 154(5):2494-503. PubMed ID: 7868915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
    Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
    J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool.
    Serreze DV; Johnson EA; Chapman HD; Graser RT; Marron MP; DiLorenzo TP; Silveira P; Yoshimura Y; Nathenson SG; Joyce S
    Diabetes; 2001 Sep; 50(9):1992-2000. PubMed ID: 11522664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.
    Anderson B; Park BJ; Verdaguer J; Amrani A; Santamaria P
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9311-6. PubMed ID: 10430939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
    Kanagawa O; Militech A; Vaupel BA
    J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells.
    Chaparro RJ; Burton AR; Serreze DV; Vignali DA; DiLorenzo TP
    J Immunol Methods; 2008 Jun; 335(1-2):106-15. PubMed ID: 18439618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
    Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
    J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience.
    Choisy-Rossi CM; Holl TM; Pierce MA; Chapman HD; Serreze DV
    J Immunol; 2004 Sep; 173(6):3791-800. PubMed ID: 15356126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.